NCT01321437 2021-01-20Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant MelanomaUniversity of California, IrvinePhase 2 Completed11 enrolled 12 charts
NCT01174238 2018-06-08A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in MelanomaUniversity of California, San FranciscoPhase 2 Completed40 enrolled 10 charts
NCT00094107 2012-06-26Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic MelanomaPfizerPhase 2 Completed32 enrolled 9 charts